References
- Carruthers J., Fagien S., Matarasso S. L., and the Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 2004; 114(6 suppl)1S–22S
- Narins R. S., Brandt F., Leyden J., Lorenc Z. P., Rubin M., Smith S. A randomized, double‐blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588–95
- Lowe N., Gifford M., Tanghetti E., Poulin Y., Goldman M., Tse Y., et al. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double‐blind, randomized, parallel‐group study. J Cosmet Laser Ther 2004; 6: 79–85
- Hedelund L., Bjerring P., Egekvist H., Haedersdal M. Ablative versus non‐ablative treatment of perioral rhytides. A randomized controlled trial with long‐term blinded clinical evaluations and non‐invasive measurements. Lasers Surg Med 2006; 38: 129–36
- Monheit G. D. Chemical peels. Skin Therapy Lett 2004; 9: 6–11
- Bhatia A. C., Dover J. S., Arndt K. A., Stewart B., Alam M. Patient satisfaction and reported long‐term therapeutic efficacy associated with 1,320 nm Nd:YAG laser treatment of acne scarring and photoaging. Dermatol Surg 2006; 32: 346–52
- Finn J. C., Cox S. E., Earl M. L. Social implications of hyperfunctional facial lines. Dermatol Surg 2003; 29: 450–5
- Carruthers J., Carruthers A. Botulinum toxin type A treatment of multiple upper facial sites: patient‐reported outcomes. Dermatol Surg 2007; 33(special issue)S10–7
- Fagien S., Cox S. E., Finn J. C., Werschler W. P., Kowalski J. W. Patient‐reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double‐blind, randomized, placebo‐controlled study. Dermatol Surg 2007; 33 special issue: S2–9
- Etcoff N. Survival of the prettiest: the science of beauty. Anchor Books, New York 1999
- Carruthers J., Carruthers A. The use of botulinum toxin type A in the upper face. Facial Plast Surg Clin N Am 2006; 14: 253–60
- Carruthers J., Carruthers A. Botulinum toxin type A in the mid and lower face and neck. Dermatol Clin 2004; 22: 151–8
- Lowe P., Patnaik R., Lowe N. Comparison of two formulations of botulinum type A for the treatment of glabellar lines: a double‐blind, randomized study. J Am Acad Dermatol 2006; 55: 975–80
- Trindade de Almeida A. R., Marques E., de Almeida J., Cunha T., Boraso R. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg 2007; 33 special issue: S37–43
- Carruthers J., Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX‐A (BOTOX) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX‐A. Dermatol Surg 2003; 29: 802–9
- Carruthers J., Carruthers A. The effect of full‐face broadband light treatments alone and in combination with bilateral crow's feet botulinum toxin type A chemodenervation. Dermatol Surg 2004; 30: 355–66
- Patel M. P., Talmor M., Nolan W. B. Botox and collagen for glabellar furrows: advantages of combination therapy. Ann Plast Surg 2004; 52: 442–7
- Yamauchi P. S., Lask G., Lowe N. J. Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing. J Cosmet Laser Ther 2004; 6: 145–8
- Stratigos A. J., Katsambas A. D. The role of topical retinoids in the treatment of photoaging. Drugs 2005; 65: 1061–72
- Binder W. J. Long‐term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins. Arch Facial Plast Surg 2006; 8: 426–31